Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
14
TRIB Quote, Financials, Valuation and Earnings
Last price:
$0.80
Seasonality move
:
12.35%
Day range:
$0.75 - $0.84
52-week range:
$0.75 - $3.55
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.15x
P/B ratio:
--
Volume:
45.6K
Avg. volume:
139.4K
1-year change:
-68%
Market cap:
$22M
Revenue:
$56.8M
EPS (TTM):
-$2.28
Earnings Data
Next earnings date for TRIB
Apr 04
2025
Most recent earnings per share
-$0.46
Beat by $0.08
(Nov 15/2024)
Consensus Estimate
-$0.54
(Nov 15/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TRIB Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 01/31/2025 | Q4 | $16.5M | -- | -- | -$0.30 | -- |
| 11/15/2024 | Q3 | $16.5M | $15.2M | -$0.46 | -$0.54 | $0.08 |
| 08/14/2024 | Q2 | $15.8M | $15.8M | -$0.73 | -$0.65 | -$0.08 |
| 05/23/2024 | Q1 | -- | $14.7M | -$0.37 | $0.02 | -$0.39 |
| 01/31/2024 | Q4 | -- | $13.4M | -$0.72 | -$0.08 | -$0.64 |
| 10/03/2023 | Q3 | -- | $14.7M | -$0.88 | -$0.07 | -$0.81 |
| 07/06/2023 | Q2 | $13.5M | $13.9M | -$0.78 | -$0.45 | -$0.33 |
| 04/11/2023 | Q1 | $18.5M | $14.8M | -$0.76 | -$0.30 | -$0.46 |
| 03/23/2023 | Q4 | $18M | $15.7M | -$1.33 | -$0.30 | -$1.03 |
| 12/15/2022 | Q3 | -- | $15.7M | -$1.18 | -- | -- |
| 06/30/2022 | Q2 | -- | $15.4M | -$1.42 | -- | -- |
| 05/25/2022 | Q1 | -- | $15.7M | -$2.50 | -- | -- |
| 03/25/2022 | Q4 | -- | $7.7M | -$0.30 | -- | -- |
| 12/15/2021 | Q3 | -- | $22M | $0.31 | -- | -- |
| 09/09/2021 | Q2 | -- | $25.8M | -$0.19 | -- | -- |
| 05/25/2021 | Q1 | -- | $25.6M | $0.36 | -- | -- |
| 03/25/2021 | Q4 | -- | $32.8M | -$2.40 | -- | -- |
| 11/17/2020 | Q3 | -- | $32M | $1.40 | -- | -- |
| 08/25/2020 | Q2 | -- | $16M | -$0.35 | -- | -- |
| 03/31/2020 | Q1 | -- | $21.2M | -$0.53 | -- | -- |
| 03/16/2020 | Q4 | -- | $21.3M | -$5.60 | -- | -- |
| 10/16/2019 | Q3 | -- | $24.6M | $0.00 | -- | -- |
| 08/20/2019 | Q2 | -- | $22.5M | -$1.30 | -- | -- |
| 05/07/2019 | Q1 | -- | $22M | -$0.05 | -- | -- |
| 03/07/2019 | Q4 | -- | $24.5M | -$5.73 | -- | -- |
| 10/23/2018 | Q3 | -- | $23.7M | $0.22 | -- | -- |
| 07/19/2018 | Q2 | -- | $25M | $0.14 | -- | -- |
| 05/01/2018 | Q1 | -- | $23.8M | $0.09 | -- | -- |
| 03/07/2018 | Q4 | -- | $24.6M | -$10.15 | -- | -- |
| 10/26/2017 | Q3 | -- | $25.6M | $0.11 | -- | -- |
| 07/20/2017 | Q2 | -- | $25.4M | $0.21 | -- | -- |
| 04/27/2017 | Q1 | -- | $23.5M | $0.25 | -- | -- |
| 03/14/2017 | Q4 | -- | $23.7M | -$22.16 | -- | -- |
| 10/25/2016 | Q3 | -- | $26.1M | -$0.12 | -- | -- |
| 07/21/2016 | Q2 | -- | $26.3M | $0.43 | -- | -- |
| 04/15/2016 | Q1 | -- | $23.5M | -$0.29 | -- | -- |
| 03/03/2016 | Q4 | -- | $24.9M | $0.53 | -- | -- |
| 10/22/2015 | Q3 | -- | $25.8M | $0.49 | -- | -- |
| 07/28/2015 | Q2 | -- | $24.3M | $0.50 | -- | -- |
| 04/30/2015 | Q1 | -- | $25.2M | $0.85 | -- | -- |
| 03/03/2015 | Q4 | -- | $26.7M | $0.88 | -- | -- |
Trinity Biotech PLC Earnings Questions
-
How Much did Trinity Biotech PLC Generate in Revenue Last Quarter?
Trinity Biotech PLC reported $15.2M worth of top line sales in its most recent quarter.
-
Did Trinity Biotech PLC Beat Earnings Last Quarter?
Trinity Biotech PLC announced earnings per share of -$0.46 which represents a beat of analyst forecast a -$0.54 per share.
-
Is Trinity Biotech PLC Profitable?
Trinity Biotech PLC reported $5.3M that represents $0.51 per share over the last quarter.
-
What is the Analyst Consensus for Trinity Biotech PLC EPS Next Year?
Trinity Biotech PLC's earnings are forecast to decrease from -$3.20 per share to -- per share next year representing a decrease of -45.63%.
-
When is Trinity Biotech PLC's Earnings Date?
Trinity Biotech PLC's next earnings date is April 4, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 2.79% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 6.8% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 5.31% over the past day.
